Benzinga Pro's Top 5 Stocks To Watch For Thurs., Mar. 12, 2020: BA, APT, UBER, APRN, CHFS

Benzinga Pro's Stocks To Watch For Thursday

• Boeing (BA) - Shares collapsed 18% on Wednesday, the stock's worst single trading session in almost 50 years. The company's market cap plunged by about $70 billion on Wednesday. Reports suggested Boeing will draw down all of a nearly $14 billion loan as a precaution and will freeze hiring. Additionally, the FAA said it did not approve the company's 737 MAX wiring bundles compliance proposal. The stock continued lower by another 14% on Thursday. JP Morgan downgraded the stock to Neutral. 
• Alpha Pro Tech (APT) - The company gave an update on sales of its N-95 facemask: between Jan. 27 and Mar. 11, the company booked $22.6 million in orders. Alpha Pro Tech said it will fulfill about $4 million of currently booked orders in Q1 and the remaining $18.6 million in early Q3. The stock was up 40%.
• Uber Technologies (UBER) - The stock was down 11% in pre-market action as fears about the company's ride-share business amid the coronavirus outbreak weighed. Reports Wednesday suggested workers of Uber and Lyft were demanding paid sick leave. Another report suggested the company could suspend accounts of drivers and passengers who have been confirmed with coronavirus infection. 
• Blue Apron (APRN) - Shares rallied on Wednesday, up 12%, as investors likely considered the implications of Americans being indoors for potentially the next couple weeks. As a provider of delivered food to consumers at home, Blue Apron is being considered a potential beneficiary to the coronavirus outbreak.
• CHF Solutions (CHFS) - Shares of this penny stock were indicated sharply higher in pre-market action, up 82% to around $0.57. The Benzinga Pro Newsdesk did not see company-specific news to justify the move higher but should be noted the company is a medical device manufacturer. Its Aquadex FlexFlow system is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy.